CHARACTERISTIC | BRITISH COLUMBIA, 2007 TO 2010, N (%)* (N = 9338) | MANITOBA, 2007 TO 2011, N (%)* (N = 2688) | ONTARIO, 2007 TO 2010, N (%)* (N = 23 700) |
---|---|---|---|
Follow-up time, y | |||
• 1 | 9338 (100.0) | 2688 (100.0) | 23 700 (100.0) |
• 2 | 8862 (94.9) | 2583 (96.1) | 22 297 (94.1) |
• 3 | 6213 (66.5) | 2037 (75.8) | 21 148 (89.2) |
• 4 | 3865 (41.4) | 1516 (56.4) | 17 255 (72.8) |
Age group, y | |||
• < 40 | 403 (4.3) | 114 (4.2) | 1353 (5.7) |
• 40–49 | 1697 (18.2) | 432 (16.1) | 4074 (17.2) |
• 50–59 | 2378 (25.5) | 715 (26.6) | 6322 (26.7) |
• 60–69 | 2449 (26.2) | 725 (27.0) | 6156 (26.0) |
• 70–74 | 860 (9.2) | 255 (9.5) | 2239 (9.4) |
• > 74 | 1551 (16.6) | 447 (16.6) | 3556 (15.0) |
Comorbidity, ADGs | |||
• 0–3 | 2913 (31.2) | 598 (22.2) | 5891 (24.9) |
• 4–5 | 2292 (24.5) | 655 (24.4) | 5472 (23.1) |
• 6–7 | 1886 (20.2) | 559 (20.8) | 5184 (21.9) |
• 8–9 | 1232 (13.2) | 434 (16.1) | 3654 (15.4) |
• ≥ 10 | 1015 (10.9) | 442 (16.4) | 3499 (14.8) |
Stage at diagnosis | |||
• I | 4178 (44.7) | 1268 (47.2) | 10 036 (42.3) |
• II | 3098 (33.2) | 1086 (40.4) | 8602 (36.3) |
• III | 1065 (11.4) | 317 (11.8) | 2660 (11.2) |
• IV | 179 (1.9) | 7 (0.3) | 88 (0.4) |
• Unknown | 818 (8.8) | 10 (0.4) | 2314 (9.8) |
ADG—Johns Hopkins Aggregated Diagnosis Group
↵* Percentages might not add to 100 owing to rounding.